MagicMed’s mission is to unlock the full potential of psychedelic-derived medicines. The company is focused on the discovery and development of novel drug candidates, structurally related to classic psychedelics but with improved pharmaceutical characteristics.
|10-11, 14-18 June 2021||Bio Digital Conference|
|17 June 2021||Psychedelics in Psychiatry and Beyond Conference (H.C. Wainwright)|
|22-23 June 2021||Psychedelic Opportunity Summit (This includes a presentation and panel discussion)|
LATEST PRESS RELEASES
Sorry, your search returned no results.
Try with different filters.